STAT Inhibitors in Cancer
(Sprache: Englisch)
This volume, which includes contributions from leading scientists and clinicians in the field, provides definitive, state-of-the-art information on STAT inhibitors in a biological and clinical context. It gives an overview of the biology of the STAT family...
Voraussichtlich lieferbar in 3 Tag(en)
versandkostenfrei
Buch (Kartoniert)
164.99 €
- Lastschrift, Kreditkarte, Paypal, Rechnung
- Kostenlose Rücksendung
- Ratenzahlung möglich
Produktdetails
Produktinformationen zu „STAT Inhibitors in Cancer “
Klappentext zu „STAT Inhibitors in Cancer “
This volume, which includes contributions from leading scientists and clinicians in the field, provides definitive, state-of-the-art information on STAT inhibitors in a biological and clinical context. It gives an overview of the biology of the STAT family of transcription factors and their role in cancer etiology. Additionally, it describes the raft of therapeutic approaches being used to inhibit STATs in the context of various cancers, covering the full spectrum of therapeutic approaches to inhibiting STATs, and presenting emerging data from clinical trials.Inhaltsverzeichnis zu „STAT Inhibitors in Cancer “
STATs in Health and Disease.- STAT Proteins in Cancer.- Translating STAT Inhibitors from the Lab to the Clinic.- Historical Development of STAT3 Inhibitors and Early Results in Clinical Trials.- STAT3 Inhibitors in Cancer: A Comprehensive Update.- Targeting Upstream Janus Kinases.- Inhibitors of Upstream Inducers of STAT ActivationAutoren-Porträt
Alister C. Ward is Foundation Professor/Director of Pre-Clinical Studies, School of Medicine, Deakin University, Geelong, Australia.
Bibliographische Angaben
- 2018, Softcover reprint of the original 1st ed. 2016, VII, 195 Seiten, 195 farbige Abbildungen, Maße: 15,5 x 23,5 cm, Kartoniert (TB), Englisch
- Herausgegeben: Alister C. Ward
- Verlag: Springer, Berlin
- ISBN-10: 3319827014
- ISBN-13: 9783319827018
Sprache:
Englisch
Kommentar zu "STAT Inhibitors in Cancer"
Schreiben Sie einen Kommentar zu "STAT Inhibitors in Cancer".
Kommentar verfassen